Skip to main content

Invesco Nasdaq Biotechnology ETF (IBBQ)

NASDAQ: IBBQ · IEX Real-Time Price · USD
23.16 -0.55 (-2.32%)
Dec 3, 2021 4:00 PM EST - Market closed
Assets$30.54M
NAV$23.67
Expense Ration/a
PE Ratio99.02
Shares Out1.29M
Dividend (ttm)$0.04
Dividend Yield0.18%
Ex-Dividend DateSep 20, 2021
1-Year Return-9.00%
Volume16,997
Open23.86
Previous Close23.71
Day's Range23.02 - 23.93
52-Week Low23.02
52-Week High23.02
Beta-1.44
Holdings265
Inception DateJun 11, 2021

About IBBQ

The investment seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index ®. The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.

Asset ClassEquity
RegionNorth America
IssuerInvesco
Stock ExchangeNASDAQ
Ticker SymbolIBBQ
Index TrackedNasdaq Biotechnology Index

Top 10 Holdings

50.49% of assets
NameSymbolWeight
AmgenAMGN8.23%
Gilead SciencesGILD8.14%
ModernaMRNA7.40%
Regeneron PharmaceuticalsREGN6.21%
IlluminaILMN5.21%
Vertex PharmaceuticalsVRTX4.71%
BiogenBIIB3.11%
SeagenSGEN2.71%
BioNTech SEBNTX2.58%
Horizon TherapeuticsHZNP2.20%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Sep 20, 2021$0.04324Sep 30, 2021
Full Dividend History

News

Moderna's Omicron Booster Strategy Lifts Biotechnology ETFs

Moderna (NasdaqGS: MRNA) jumped on Monday after announcing that a higher dosage booster of its vaccine could help mitigate COVID-19 Omicron risks before a tailor-made shot is finalized, lifting biotechn...

Other symbols:IBB
4 days ago - ETF Trends

Position for Biotech Rebound With Quality Names

Broadly speaking, 2021 hasn't been kind to biotechnology stocks and exchange traded funds, but some market participants remain optimistic regarding a rebound for these previously beloved assets. One way...

1 month ago - ETF Trends

An ETF to Watch for Amidst the Vaccine Push

While Covid-19 variants on the rise, the push for more vaccinations make the Invesco Nasdaq Biotechnology ETF (IBBQ) an ETF to watch. As Covid cases experience a resurgence, more companies are mandating...

3 months ago - ETF Trends

New Biotechnology ETF Could Be a Stellar Second Half Idea

The Invesco Nasdaq Biotechnology ETF (IBBQ) is just a few weeks old, but even with that rookie status, it could be a stellar second half idea. On the back of the Food and Drug Administration (FDA) condi...

5 months ago - ETF Trends

A Biotech ETF to Track Nasdaq's Industry-Setting Benchmark

As investors consider the regulatory, scientific, and demographic factors driving today's growth in biotechnology industry, they can look to the Nasdaq Biotechnology Index's methodology and one related ...

5 months ago - ETF Trends

The Biotech Trek: A Short History from 1993 to 2021

The Nasdaq Biotechnology Index (NBI) launched in 1993, when the industry was still in the midst of the original “biotech revolution.” Since then, its constituent basket has swelled from roughly 100 comp...

5 months ago - ETF Trends